{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:45:10Z","timestamp":1792586710439,"version":"4.5.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jiac.2021.05.012","type":"journal-article","created":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T13:33:14Z","timestamp":1621517594000},"page":"1131-1136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Complicated urinary tract infections with diabetes mellitus"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0069-7392","authenticated-orcid":false,"given":"Jun","family":"Kamei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2021.05.012_bib1","unstructured":"McCormick KA, Moore SR, Siegel R, United S, Agency for Health Care P, Research, et al. Clinical practice guideline development : methodology perspectives. Rockville, MD (Executive Office Center, Suite 501, 2101 E. Jefferson. St., Rockville 20852): U.S. Dept. of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research."},{"key":"10.1016\/j.jiac.2021.05.012_bib2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/iju.13493","article-title":"Summary of the uaa-aaus guidelines for urinary tract infections","volume":"25","author":"Choe","year":"2018","journal-title":"Int J Urol"},{"key":"10.1016\/j.jiac.2021.05.012_bib3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/oxfordjournals.aje.a000181","article-title":"Risk of urinary tract infection and asymptomatic bacteriuria among diabetic and nondiabetic postmenopausal women","volume":"161","author":"Boyko","year":"2005","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jiac.2021.05.012_bib4","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.2337\/diacare.25.10.1778","article-title":"Diabetes and the risk of acute urinary tract infection among postmenopausal women","volume":"25","author":"Boyko","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jiac.2021.05.012_bib5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1086\/431587","article-title":"Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus","volume":"41","author":"Muller","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2021.05.012_bib6","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jdiacomp.2014.06.009","article-title":"Risk characterization for urinary tract infections in subjects with newly diagnosed type 2 diabetes","volume":"28","author":"Fu","year":"2014","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.jiac.2021.05.012_bib7","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jdiacomp.2012.06.008","article-title":"Incidence of urinary tract infection among patients with type 2 diabetes in the UK general practice research database (gprd)","volume":"26","author":"Hirji","year":"2012","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.jiac.2021.05.012_bib8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0924-8579(00)00356-3","article-title":"Urinary tract infections in adults with diabetes","volume":"17","author":"Ronald","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2021.05.012_bib9","first-page":"129","article-title":"Urinary tract infections in patients with type 2 diabetes mellitus: review of prevalence, diagnosis, and management","volume":"8","author":"Nitzan","year":"2015","journal-title":"Diabetes, Metab Syndrome Obes Targets Ther"},{"key":"10.1016\/j.jiac.2021.05.012_bib10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.7326\/0003-4819-142-1-200501040-00008","article-title":"Risk factors associated with acute pyelonephritis in healthy women","volume":"142","author":"Scholes","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jiac.2021.05.012_bib11","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/clinids\/22.6.1051","article-title":"Hospitalization for acute pyelonephritis in manitoba, Canada, during the period from 1989 to 1992: impact of diabetes, pregnancy, and aboriginal origin","volume":"22","author":"Nicolle","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2021.05.012_bib12","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/brain\/aww038","article-title":"Trpa1 mediates trigeminal neuropathic pain in mice downstream of monocytes\/macrophages and oxidative stress","volume":"139","author":"Trevisan","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.jiac.2021.05.012_bib13","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.2337\/diacare.23.12.1737","article-title":"Risk factors for symptomatic urinary tract infection in women with diabetes","volume":"23","author":"Geerlings","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jiac.2021.05.012_bib14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jmii.2011.12.024","article-title":"Bacterial characteristics and glycemic control in diabetic patients with escherichia coli urinary tract infection","volume":"46","author":"Wang","year":"2013","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jiac.2021.05.012_bib15","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.juro.2009.07.090","article-title":"Diabetes mellitus and urinary tract infection: epidemiology, pathogenesis and proposed studies in animal models","volume":"182","author":"Chen","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.jiac.2021.05.012_bib16","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1099\/00222615-48-6-535","article-title":"Effect of glucose and ph on uropathogenic and non-uropathogenic escherichia coli: studies with urine from diabetic and non-diabetic individuals","volume":"48","author":"Geerlings","year":"1999","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jiac.2021.05.012_bib17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1055\/s-2007-979789","article-title":"Elevated glucose levels stimulate transforming growth factor-\u03b21 (tgf-\u03b21), suppress interleukin il-2, il-6 and il-10 production and DNA synthesis in peripheral blood mononuclear cells","volume":"28","author":"Reinhold","year":"1996","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.jiac.2021.05.012_bib18","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1046\/j.1365-2362.2000.00745.x","article-title":"Cytokine secretion is impaired in women with diabetes mellitus","volume":"30","author":"Geerlings","year":"2000","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jiac.2021.05.012_bib19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V","article-title":"Impaired leucocyte functions in diabetic patients","volume":"14","author":"Delamaire","year":"1997","journal-title":"Diabet Med"},{"key":"10.1016\/j.jiac.2021.05.012_bib20","first-page":"442","article-title":"Type 2 diabetes and its impact on the immune system","volume":"16","author":"Berbudi","year":"2020","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.jiac.2021.05.012_bib21","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.2337\/diacare.25.8.1405","article-title":"Adherence of type 1-fimbriated escherichia coli to uroepithelial cells: more in diabetic women than in control subjects","volume":"25","author":"Geerlings","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jiac.2021.05.012_bib22","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.2337\/dc09-0516","article-title":"Prevalence and risk factors for urinary incontinence in overweight and obese diabetic women: action for health in diabetes (look ahead) study","volume":"32","author":"Phelan","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jiac.2021.05.012_bib23","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.urology.2008.11.009","article-title":"Risk factors for urinary incontinence among women with type 1 diabetes: findings from the epidemiology of diabetes interventions and complications study","volume":"73","author":"Sarma","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.jiac.2021.05.012_bib24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.18869\/acadpub.cmm.2.3.10","article-title":"Characterization and identification of candiduria due to candida species in diabetic patients","volume":"2","author":"Falahati","year":"2016","journal-title":"Curr Med Mycol"},{"key":"10.1016\/j.jiac.2021.05.012_bib25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.mycmed.2017.04.005","article-title":"Candiduria: evidence-based approach to management, are we there yet?","volume":"27","author":"Alfouzan","year":"2017","journal-title":"J Mycol Med"},{"key":"10.1016\/j.jiac.2021.05.012_bib26","doi-asserted-by":"crossref","first-page":"445","DOI":"10.5152\/tud.2018.54069","article-title":"Candiduria; a review article with specific data from Iran","volume":"44","author":"Gharaghani","year":"2018","journal-title":"Turk J Urol"},{"key":"10.1016\/j.jiac.2021.05.012_bib27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12941-015-0082-4","article-title":"Urinary tract infections and antimicrobial sensitivity among diabetic patients at khartoum, Sudan","volume":"14","author":"Hamdan","year":"2015","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.jiac.2021.05.012_bib28","first-page":"945","article-title":"Antimicrobial resistance pattern in escherichia coli causing urinary tract infection among inpatients","volume":"139","author":"Niranjan","year":"2014","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.jiac.2021.05.012_bib29","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/j.1464-5491.2004.01169.x","article-title":"Diabetes mellitus in itself is not a risk factor for antibiotic resistance in escherichia coli isolated from patients with bacteriuria","volume":"21","author":"Meiland","year":"2004","journal-title":"Diabet Med"},{"key":"10.1016\/j.jiac.2021.05.012_bib30","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10096-003-1084-2","article-title":"Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients","volume":"23","author":"Colodner","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2021.05.012_bib31","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2165\/00002512-200118040-00002","article-title":"A practical guide to antimicrobial management of complicated urinary tract infection","volume":"18","author":"Nicolle","year":"2001","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jiac.2021.05.012_bib32","doi-asserted-by":"crossref","first-page":"40","DOI":"10.5414\/CN107216","article-title":"Urinary tract infection in patients with diabetes mellitus","volume":"77","author":"Funfstuck","year":"2012","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.jiac.2021.05.012_bib33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0924-8579(03)00234-6","article-title":"Pathogenesis and management of bacterial urinary tract infections in adult patients with diabetes mellitus","volume":"22","author":"Hoepelman","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2021.05.012_bib34","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1086\/650482","article-title":"Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 international clinical practice guidelines from the infectious diseases society of America","volume":"50","author":"Hooton","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2021.05.012_bib35","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s10156-012-0467-7","article-title":"A randomized clinical trial to evaluate the preventive effect of cranberry juice (ur65) for patients with recurrent urinary tract infection","volume":"19","author":"Takahashi","year":"2013","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2021.05.012_bib36","first-page":"227","article-title":"Natural approaches to prevention and treatment of infections of the lower urinary tract","volume":"13","author":"Head","year":"2008","journal-title":"Alternative Med Rev"},{"key":"10.1016\/j.jiac.2021.05.012_bib37","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1111\/j.1532-5415.2009.02550.x","article-title":"Effect of diabetes mellitus on the clinical and microbiological features of hospitalized elderly patients with acute pyelonephritis","volume":"57","author":"Kofteridis","year":"2009","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jiac.2021.05.012_bib38","first-page":"281","article-title":"Diabetes mellitus and bacteraemia: a comparative study between diabetic and non-diabetic patients","volume":"1","author":"Carton","year":"1992","journal-title":"Eur J Med"},{"key":"10.1016\/j.jiac.2021.05.012_bib39","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1056\/NEJM199912163412507","article-title":"Infections in patients with diabetes mellitus","volume":"341","author":"Joshi","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2021.05.012_bib40","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jinf.2014.05.002","article-title":"Comparison of the clinical characteristics of diabetic and non-diabetic women with community-acquired acute pyelonephritis: a multicenter study","volume":"69","author":"Kim","year":"2014","journal-title":"J Infect"},{"key":"10.1016\/j.jiac.2021.05.012_bib41","first-page":"735","article-title":"Bacterial urinary tract infections in diabetes","volume":"11","author":"Patterson","year":"1997","journal-title":"Infect Dis Clin"},{"key":"10.1016\/j.jiac.2021.05.012_bib42","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00134-018-5085-0","article-title":"The surviving sepsis campaign bundle: 2018 update","volume":"44","author":"Levy","year":"2018","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jiac.2021.05.012_bib43","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jiac.2017.02.002","article-title":"Jaid\/jsc guidelines for clinical management of infectious disease 2015 - urinary tract infection\/male genital infection","volume":"23","author":"Yamamoto","year":"2017","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2021.05.012_bib44","first-page":"837","article-title":"Urosepsis--etiology, diagnosis, and treatment","volume":"112","author":"Dreger","year":"2015","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.jiac.2021.05.012_bib45","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.euf.2018.11.003","article-title":"Management of urosepsis in 2018","volume":"5","author":"Bonkat","year":"2019","journal-title":"European Urology Focus"},{"key":"10.1016\/j.jiac.2021.05.012_bib46","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2337\/dc10-0421","article-title":"Meta-analysis of the significance of asymptomatic bacteriuria in diabetes","volume":"34","author":"Renko","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jiac.2021.05.012_bib47","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.numecd.2016.07.006","article-title":"Genitourinary infections in diabetic patients in the new era of diabetes therapy with sodium-glucose cotransporter-2 inhibitors","volume":"26","author":"Rizzi","year":"2016","journal-title":"Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.jiac.2021.05.012_bib48","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00345-005-0042-2","article-title":"Microbiological outcomes in women with diabetes and untreated asymptomatic bacteriuria","volume":"24","author":"Nicolle","year":"2006","journal-title":"World J Urol"},{"key":"10.1016\/j.jiac.2021.05.012_bib49","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMoa021042","article-title":"Antimicrobial treatment in diabetic women with asymptomatic bacteriuria","volume":"347","author":"Harding","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2021.05.012_bib50","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.juro.2007.05.017","article-title":"Risk factors for mortality in patients with emphysematous pyelonephritis: a meta-analysis","volume":"178","author":"Falagas","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.jiac.2021.05.012_bib51","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.juro.2008.01.019","article-title":"Is percutaneous drainage the new gold standard in the management of emphysematous pyelonephritis? Evidence from a systematic review","volume":"179","author":"Somani","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.jiac.2021.05.012_bib52","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1111\/j.1464-410X.2010.09660.x","article-title":"Emphysematous pyelonephritis","volume":"107","author":"Ubee","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.jiac.2021.05.012_bib53","first-page":"125","article-title":"Clinical characteristics of emphysematous pyelonephritis","volume":"34","author":"Tang","year":"2001","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jiac.2021.05.012_bib54","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nrurol.2009.51","article-title":"Current management of emphysematous pyelonephritis","volume":"6","author":"Pontin","year":"2009","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.jiac.2021.05.012_bib55","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/archinte.160.6.797","article-title":"Emphysematous pyelonephritis: clinicoradiological classification, management, prognosis, and pathogenesis","volume":"160","author":"Huang","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jiac.2021.05.012_bib56","doi-asserted-by":"crossref","first-page":"16618","DOI":"10.1038\/s41598-019-52989-7","article-title":"Predicting need for intensive care unit admission in adult emphysematous pyelonephritis patients at emergency departments: comparison of five scoring systems","volume":"9","author":"Yap","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jiac.2021.05.012_bib57","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000489431","article-title":"Risk of sofa deterioration in conservative treatment for emphysematous pyelonephritis: pitfalls of current trends in therapeutics from multicenter clinical experience","volume":"12","author":"Ozawa","year":"2019","journal-title":"Curr Urol"},{"key":"10.1016\/j.jiac.2021.05.012_bib58","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.4103\/2230-8210.119512","article-title":"Genitourinary infection in diabetes","volume":"17","author":"Julka","year":"2013","journal-title":"Indian journal of endocrinology and metabolism"},{"key":"10.1016\/j.jiac.2021.05.012_bib59","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.05.2009.1832","article-title":"Emphysematous cystitis: radiological diagnosis of complicated urinary tract infection","author":"Middela","year":"2009","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jiac.2021.05.012_bib60","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1464-410X.2007.06930.x","article-title":"Emphysematous cystitis: a review of 135 cases","volume":"100","author":"Thomas","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.jiac.2021.05.012_bib61","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.urology.2012.02.023","article-title":"Clinical outcomes of nonoperative management in emphysematous urinary tract infections","volume":"79","author":"Bjurlin","year":"2012","journal-title":"Urology"},{"key":"10.1016\/j.jiac.2021.05.012_bib62","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2169\/internalmedicine.53.1121","article-title":"Emphysematous cystitis: a review of the literature","volume":"53","author":"Amano","year":"2014","journal-title":"Intern Med"},{"key":"10.1016\/j.jiac.2021.05.012_bib63","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/089277904322836677","article-title":"Multiphasic helical ct diagnosis of early medullary and papillary necrosis","volume":"18","author":"Lang","year":"2004","journal-title":"J Endourol"},{"key":"10.1016\/j.jiac.2021.05.012_bib64","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/0002-9343(60)90012-7","article-title":"Renal medullary necrosis","volume":"29","author":"Lauler","year":"1960","journal-title":"Am J Med"},{"key":"10.1016\/j.jiac.2021.05.012_bib65","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2337\/diacare.12.3.198","article-title":"Renal papillary necrosis in patients with iddm","volume":"12","author":"Groop","year":"1989","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jiac.2021.05.012_bib66","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0009-9260(05)80197-7","article-title":"Case report: computed tomography demonstration of renal papillary necrosis","volume":"44","author":"Saifuddin","year":"1991","journal-title":"Clin Radiol"},{"key":"10.1016\/j.jiac.2021.05.012_bib67","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bcp.2015.09.005","article-title":"Sglt2 inhibitors","volume":"101","author":"Dardi","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jiac.2021.05.012_bib68","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1472-6823-13-58","article-title":"Sodium glucose co-transport 2 inhibitors in the treatment of type 2 diabetes mellitus: a meta-analysis of randomized double-blind controlled trials","volume":"13","author":"Berhan","year":"2013","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.jiac.2021.05.012_bib69","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jdiacomp.2015.07.011","article-title":"Efficacy and safety of sodium\u2013glucose cotransporter 2 inhibitors in type 2 diabetes: a meta-analysis of randomized controlled trials for 1 to 2 years","volume":"29","author":"Liu","year":"2015","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.jiac.2021.05.012_bib70","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jdiacomp.2013.04.012","article-title":"Vulvovaginitis and balanitis in patients with diabetes treated with dapagliflozin","volume":"27","author":"Johnsson","year":"2013","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.jiac.2021.05.012_bib71","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/dmrr.2494","article-title":"The safety of dipeptidyl peptidase-4 (dpp-4) inhibitors or sodium-glucose cotransporter 2 (sglt-2) inhibitors added to metformin background therapy in patients with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"30","author":"Kawalec","year":"2014","journal-title":"Diabetes Metabol Res Rev"},{"key":"10.1016\/j.jiac.2021.05.012_bib72","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1590\/1806-9282.65.2.246","article-title":"Use of sodium-glucose cotransporter-2 inhibitors and urinary tract infections in type 2 diabetes patients: a systematic review","volume":"65","author":"Figueiredo","year":"2019","journal-title":"Rev Assoc M\u00e9d Bras"},{"key":"10.1016\/j.jiac.2021.05.012_bib73","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00592-018-1116-0","article-title":"Sglt-2 inhibitors and the risk of infections: a systematic review and meta-analysis of randomized controlled trials","volume":"55","author":"Puckrin","year":"2018","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.jiac.2021.05.012_bib74","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1038\/s41598-017-02733-w","article-title":"Effects of sglt2 inhibitors on utis and genital infections in type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"7","author":"Liu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jiac.2021.05.012_bib75","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/dom.12825","article-title":"Urinary tract and genital infections in patients with type 2 diabetes treated with sodium-glucose co-transporter 2 inhibitors: a meta-analysis of randomized controlled trials","volume":"19","author":"Li","year":"2017","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.jiac.2021.05.012_bib76","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1111\/dom.13820","article-title":"Sodium glucose cotransporter 2 inhibitors and risk of genital mycotic and urinary tract infection: a population-based study of older women and men with diabetes","volume":"21","author":"Lega","year":"2019","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.jiac.2021.05.012_bib77","doi-asserted-by":"crossref","first-page":"248","DOI":"10.7326\/M18-3136","article-title":"Sodium-glucose cotransporter-2 inhibitors and the risk for severe urinary tract infections: a population-based cohort study","volume":"171","author":"Dave","year":"2019","journal-title":"Ann Intern Med"},{"issue":"Suppl 1","key":"10.1016\/j.jiac.2021.05.012_bib78","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.amjcard.2019.10.029","article-title":"Safety of sodium-glucose co-transporter 2 inhibitors","volume":"124","author":"McGill","year":"2019","journal-title":"Am J Cardiol"},{"issue":"Suppl 2","key":"10.1016\/j.jiac.2021.05.012_bib79","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/dom.13611","article-title":"A safety update on sodium glucose co-transporter 2 inhibitors","volume":"21","author":"Fitchett","year":"2019","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.jiac.2021.05.012_bib80","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/dom.13531","article-title":"Comparative risk of genital infections associated with sodium-glucose co-transporter-2 inhibitors","volume":"21","author":"Dave","year":"2019","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.jiac.2021.05.012_bib81","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2217\/whe-2016-0001","article-title":"Benefits\/risks of sodium\u2013glucose co-transporter 2 inhibitor canagliflozin in women for the treatment of type 2 diabetes","volume":"12","author":"Kushner","year":"2016","journal-title":"Women's Health"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X21001410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X21001410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:02:14Z","timestamp":1761159734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X21001410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":81,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S1341321X21001410"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2021.05.012","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complicated urinary tract infections with diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2021.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}